why choose us

First received: May 10, 2023

Clinical Trial: A Pilot Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Post COVID-19 Cognitive Impairment

Study Type: INTERVENTIONAL


Official Title: A Pilot Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment

Brief Summary: Some people who have been infected with the virus that causes COVID-19 can experience long-term effects from their infection, known as post COVID-19 conditions (PCC) or long COVID1.The medical circles often describe it as post-acute sequelae of Covid-19 (PASC).People with post-COVID conditions can have a wide range of symptoms that can last more than four weeks or even months after infection.Sometimes the symptoms can even go away or come back again.The Centers for Disease and Prevention (CDC) listed a…

Read more